Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genextra S.p.A.
DescriptionSmall molecule inhibitor of mitochondrial permeability transition pore (mPTP)
Molecular Target Mitochondrial permeability transition pore (mPTP)
Mechanism of ActionMitochondrial inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat cardiac reperfusion injury that contributes significantly to the morbidity and mortality subsequent to myocardial infarction (MI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today